EFNB2 and neoplasm: Our data suggest a model in which ephrinB2 loss promotes GBM invasion by increasing the intrinsic invasive capacity of tumour cells and by avoiding repulsive interactions with the EphB2/B4 expressing parenchyma, thereby reducing tumour compartmentalization.